Our sample-focused analysis followed a triad of turning points between the pancreas and parathyroid with the confirmation of primary hyperparathyroidism: hypercalcemia-linked pancreatitis, MEN1 gene pathogenic variants, and insulin resistance. The gene discussed is INS; the disease is primary hyperparathyroidism.